Hostname: page-component-745bb68f8f-kw2vx Total loading time: 0 Render date: 2025-01-15T16:50:53.075Z Has data issue: false hasContentIssue false
  • English
  • Français

Avonex® PEN Satisfaction and Patients Experience Clinical Trial

Published online by Cambridge University Press:  10 January 2017

Stephanie Wong ,
Vladimir Migounov ,
Trudy L. Campbell ,
Mark Morreale  and
Emma Cass
Stephanie Wong
Affiliation:
Innomar Strategies Inc./ AmerisourceBergen Canada, Burlington, Email: swong@innomar-strategies.com
Vladimir Migounov
Affiliation:
Biogen Idec Canada Inc., Mississauga, Ontario
Trudy L. Campbell
Affiliation:
Dalhousie University and QEII Health Sciences Centre, Halifax, Nova Scotia, Canada
Mark Morreale
Affiliation:
Innomar Strategies Inc./ AmerisourceBergen Canada, Burlington, Email: swong@innomar-strategies.com
Emma Cass
Affiliation:
Innomar Strategies Inc./ AmerisourceBergen Canada, Burlington, Email: swong@innomar-strategies.com
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Canadian Journal of Neurological Sciences , Volume 40 , Issue 6 , November 2013 , pp. 898 - 899
Copyright
Copyright © The Canadian Journal of Neurological 1999

References

1. Costello, K, Kennedy, P, Scanzillo, J. Recognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long term. Medscape J Med. 2008;10(9):225.Google Scholar
2. Singer, B, Wray, S, Miller, T, et al. Patient-rated ease of use and functional reliability of an electronic autoinjector for self-injection of subcutaneous interferon beta-1a for relapsing multiple sclerosis. Mult Scler Relat Disord. 2012;1:87–94.Google Scholar
3. Lugaresi, A. Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation? Expert Opin Drug Deliv. 2009;6(9):995–1002.Google Scholar
4. Mikol, D, Lopez-Bresnaham, M, Taraskiewicz, S, Chang, P, Rangnow, J (The Rebiject Study Group). A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-la (Rebif®) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis. Mult Scler. 2005;11:585–591.Google Scholar
5. Phillips, JT, Fox, E, Grainger, W, Tuccillo, D, Liu, S, Deykin, A. An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an AVONEX® prefilled syringe in multiple sclerosis patients. BMC Neurol. 2011;11:126.Google Scholar